“…However, equipment and maintenance, as well as sample running costs are a considerable drawback of these methods [35,36]. For the detection of CBD and/or THC in human plasma, bioanalytical methods had been developed using radioactivity assays [37], high-performance liquid chromatography (HPLC)-UV detection [38], HPLC-electrochemical detection [39], gas chromatography-mass spectrometry (GC-MS) [40][41][42][43], and LC-MS [43,44]. However, issues of unspecific detection and/or high blood sampling volumes needed for the analysis preclude the use of these methods to conduct pharmacokinetic studies in rats.…”